ALS-6000-101 Phase 1a Three-Weekly Dose Escalation Safety Study Data
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| AVOCENT (NASDAQ: AVCT) | Delayed: 0.60 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.60 | 52 Week High | $25.13 | |||
| Open | $1.29 | 52 Week Low | $9.89 | |||
| Day High | $0.60 | P/E | N/A | |||
| Day Low | $0.60 | EPS | $-1.04 | |||
| Volume | 11,813 | |||||
